The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma.
Jia SQ, Zhuo R, Zhang ZM, Yang Y, Tao YF, Wang JW, Li XL, Xie Y, Li G, Wu D, Chen YL, Yu JJ, Feng CX, Li ZH, Zhou RF, Yang RD, Yang PC, Zhou B, Wan XM, Wu YM, Jiao WY, Zhou NN, Fang F, Pan J.
Jia SQ, et al. Among authors: pan j.
J Immunol Res. 2022 Nov 16;2022:7945884. doi: 10.1155/2022/7945884. eCollection 2022.
J Immunol Res. 2022.
PMID: 36438198
Free PMC article.